Want to see IN:AARTIDRUGS full AI Analyst Report?
Aarti Drugs Limited (AARTIDRUGS) Stock Statistics & Valuation Metrics
Total Valuation
Aarti Drugs Limited has a market cap or net worth of INR 39.77B. The enterprise value is INR 34.83B.
- Market Cap
- INR 39.77B
- Enterprise Value
- INR 34.83B
Share Statistics
Aarti Drugs Limited has 91,270,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 91,270,000
- Owned by Insiders
- ―
- Owned by Institutions
- 0.95%
Financial Efficiency
Aarti Drugs Limited’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 10.12%.
- Return on Equity (ROE)
- 0.13
- Return on Assets (ROA)
- 0.07
- Return on Invested Capital (ROIC)
- 10.12%
- Return on Capital Employed (ROCE)
- 0.13
- Revenue Per Employee
- 24.11M
- Profits Per Employee
- 1.83M
- Employee Count
- 1,064
- Asset Turnover
- 0.91
- Inventory Turnover
- 3.70
Valuation Ratios
The current PE Ratio of Aarti Drugs Limited is 20.96. Aarti Drugs Limited’s PEG ratio is 16.67.
- PE Ratio
- 20.96
- PS Ratio
- 1.50
- PB Ratio
- 2.59
- Price to FCF
- 69.02
- Price to Operating Cash Flow
- 26.30
- PEG Ratio
- 16.67
Income Statement
In the last 12 months, Aarti Drugs Limited had revenue of 25.65B and earned 1.95B in profits. Earnings per share was 21.36.
- Revenue
- 25.65B
- Gross Profit
- 7.50B
- Operating Income
- 2.42B
- Pretax Income
- 2.11B
- Net Income
- 1.95B
- EBITDA
- 3.12B
- Earnings Per Share (EPS)
- 21.36
Cash Flow
In the last 12 months, operating cash flow was 1.52B and capital expenditures -943.10M, giving a free cash flow of 580.50M billion.
- Operating Cash Flow
- 1.52B
- Free Cash Flow
- 580.50M
- Free Cash Flow per Share
- 6.36
Dividends & Yields
Aarti Drugs Limited pays an annual dividend of INR 1.00, resulting in a dividend yield of 0.46%
- Dividend Per Share
- INR 1.00
- Dividend Yield
- 0.46%
- Payout Ratio
- 4.59%
- Free Cash Flow Yield
- 1.45%
- Earnings Yield
- 4.77%
Stock Price Statistics
- Beta
- 1.01
- 52-Week Price Change
- -13.22%
- 50-Day Moving Average
- 418.95
- 200-Day Moving Average
- 388.33
- Relative Strength Index (RSI)
- 59.00
- Average Volume (3m)
- 17.46K
Important Dates
Aarti Drugs Limited upcoming earnings date is Nov 03, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Jul 31, 2026
- Next Earnings Date
- Nov 03, 2026
- Ex-Dividend Date
- Feb 04, 2025
Financial Position
Aarti Drugs Limited as a current ratio of 1.59, with Debt / Equity ratio of 37.23%
- Current Ratio
- 1.59
- Quick Ratio
- 1.06
- Debt to Market Cap
- 0.20
- Net Debt to EBITDA
- 1.82
- Interest Coverage Ratio
- 7.19
Taxes
In the past 12 months, Aarti Drugs Limited has paid 159.60M in taxes.
- Income Tax
- 159.60M
- Effective Tax Rate
- 0.08
Enterprise Valuation
Aarti Drugs Limited EV to EBITDA ratio is 13.69, with an EV/FCF ratio of 78.80.
- EV to Sales
- 1.71
- EV to EBITDA
- 13.69
- EV to Free Cash Flow
- 78.80
- EV to Operating Cash Flow
- 30.02
Balance Sheet
Aarti Drugs Limited has INR 242.80M in cash and marketable securities with INR 5.77B in debt, giving a net cash position of -INR 5.52B billion.
- Cash & Marketable Securities
- INR 242.80M
- Total Debt
- INR 5.77B
- Net Cash
- -INR 5.52B
- Net Cash Per Share
- -INR 60.52
- Tangible Book Value Per Share
- INR 168.03
Margins
Gross margin is 31.68%, with operating margin of 9.81%, and net profit margin of 7.14%.
- Gross Margin
- 31.68%
- Operating Margin
- 9.81%
- Pretax Margin
- 8.55%
- Net Profit Margin
- 7.14%
- EBITDA Margin
- 12.48%
- EBIT Margin
- 9.84%
Analyst Forecast
The average price target for Aarti Drugs Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 10.54%
- EPS Growth Forecast
- 1.27%
Scores
- Smart Score
- ―
- AI Score
- 57